Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Sexually Transmitted Diseases|August 29, 2015
Remembering the Children: Implementation and Success of a Robust Method for Identifying and Testing Children of HIV PatientsChristopher Darlow, Peter Tovey, Fiona Wallis, et al.
Wellcome Open Research|May 30, 2023
LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasisCharles Lacey, Ahmed Musa, El Tahir Khalil, et al.
Plos One|September 18, 2012
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301)Ute Jentsch, Precious Lunga, Charles Lacey, et al.
Vaccine|December 17, 2013
The burden of human papillomavirus infections and related diseases in sub-saharan AfricaHugo De Vuyst, Laia Alemany, Charles Lacey, et al.
Sexually Transmitted Diseases|November 30, 2005
A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteersSheena McCormack, Vicky Jespers, Naomi Low-Beer, et al.
Plos One|October 27, 2015
Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular AntibodiesAlexander Badamchi-Zadeh, Paul F McKay, Martin J Holland, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
Vaccine|November 28, 2025
Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trialSusan A Kelly, John Changalucha, Donati Malibwa, et al.
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.
International Journal of Cancer|May 25, 2012
EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseMarc Arbyn, Silvia de Sanjosé, Mona Saraiya, et al.
Pageof 2